Copyright
©The Author(s) 2023.
World J Hepatol. Oct 27, 2023; 15(10): 1091-1108
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1091
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1091
No. | Flavonoids | Model | Upregulated molecules | Downregulated molecules | Mechanism | Ref. |
1 | Mallotus apelta (Lour.) Muell.Arg. leaf | Rat | IkBa, SOD, GSH-Px | HYP, PC-III, Col-I, HA, LN, α-SMA, Col-III, MDA, TNF-α, IL-1β, IL-6, MMP-2/9, TIMP-1, TGF-β1/Smad, IKKβ, NF-κB p65, pNF-κBp65, IκBα, p-IκBα | Improving hepatic fibrosis and reducing ECM accumulation are related to inhibiting OS and regulating the TGF-β1/Smad signaling pathway and NF-κB-dependent inflammatory response | Zhang et al[117] |
2 | Bidens bipinnata L. | Rat | SOD, GSH-Px | NF-κB, α-SMA, TGF-β1 | Inhibiting OS to improve liver injury and protect rats from CCl4-induced hepatic fibrosis | Yuan et al[118] |
3 | Puerarin | Rat | SOD, CAT | TG, TCHO, LDL, α-SMA, Col-I/III, MDA, IL-1β, IL-6, TNF-α, MCP-1, NF-κB/p65, TGF-β, TGF-β/Smad2/3 | Inhibiting OS and inflammation associated with NF-κB signal inactivation, thereby blocking the upregulation of pro-inflammatory cytokines (IL-1β and TNF-α) and chemokines (MCP-1), ultimately improving hepatic fibrosis | Hou et al[119] |
4 | Hesperidin | Mice | ROS | Regulating liver OS and alleviating mitochondrial dysfunction to reduce fibrosis | Li et al[120] | |
5 | Alpinetin | Mice | IL-10, CAT, GSH-Px, SOD, GSH, Nrf2 | HYP, α-SMA, fibronectin, α1(I) procollagen, IL-1β, IL-6, TNF-α, Cox-2, iNOS, MDA, VEGF, VEGFR2, PDGF-βR, HIF-1α | Preventing and treating hepatic fibrosis by inhibiting the anti-inflammatory activity mediated by NLRP3 and the anti-OS activity mediated by Nrf2 | Zhu et al[121] |
6 | Fisetin | Rat | GSH, GSK-3β | MDA, TNF-α, IL-6, TGF-β1, Col-I, TIMP-1, Wnt3a, β-catenin, α-SMA, Cyclin D1 | Inhibiting liver OS can suppress Wnt/β-catenin pathway and inhibit HSC activation and proliferation, regulate MMP-9 and TIMP-1, and suppress multiple pro-fibrotic factors, to prevent and treat hepatic fibrosis | El-Fadaly et al[122] |
7 | Glabridin | Mice | PPAR-γ, GSH, T-AOC | α-SMA, fibronectin, Col-α1(I), MDA | Activation of PPARγ can inhibit inflammation and OS, thereby inhibiting HSC activation and hepatic fibrosis | Zhang et al[123] |
8 | Morin | Rat | GSH | NO, HYP, TNF-α, iNOS, NF-κB (p65) | Receiving MDA and nitric oxide levels elevation, and restoring GSH to normal levels can inhibit OS and improve hepatic fibrosis | Heeba and Mahmoud[124] |
9 | Astilbin | Rat | SOD, GSH, GCLC, GCLM, HO-1, NQO1, Nrf2 | TGF-β, Col-I/III, HYP, TNF-α, IL-1β, IL-6, MDA | Significant reduction in collagen production, inflammation and OS in vivo can prevent CCL4-induced hepatic fibrosis in rats | Sun et al[125] |
No. | Glycosides | Model | Upregulated molecules | Downregulated molecules | Mechanism | Ref. |
1 | Wogonoside | Rat | SOD, GSH, IL-10 | HA, LN, HYP, MDA, TNF-α, IL-1β, IL-6, TGF-β, MMP-2/9, Smad-3, PI3K/Akt/mTOR, NF-κB p65, PI3K/Akt/mTOR/p70S6K, α-SMA, Col-I | Inhibition of OS can improve hepatic fibrosis | Wang et al[126] |
2 | Hyperoside | Mice | SOD, GSH-Px, CAT, GSH, Nrf2 | GOT, GPT, MDA, TGF-β, Col-I/III | Activating Nrf2 nuclear translocation, inhibiting OS to increase antioxidant and phase II detoxifying enzyme activity can improve hepatic fibrosis | Zou et al[127] |
3 | Forsythiaside A | Mice | SOD, GSH, CAT, GSH-Px, p450 7a1, FXR, SHP, LRH-1, BSEP, NTCP, OATP-1 | HA, LN, PC-III, Col-I/IV, HYP, α-SMA, TNF-α, IL-1β, IL-6, LCA, DCA, HDCA, β-MCA, alloLCA, NorDCA, NorCA, CA, FGF-R4, MRP-2 | Inhibiting OS and inflammation, regulating gut microbiota and BA metabolism can improve hepatic fibrosis | Fu et al[128] |
No. | Single herbal extracts | Model | Upregulated molecules | Downregulated molecules | Mechanism | Ref. |
1 | Salvia miltiorrhiza | Mice | SOD, GSH | Col-1/III, TGF-β, MDA, IL-1α, TNF-α | Reducing MDA content, increasing SOD activity and GSH content, and suppressing OS while also reducing TNF-α and IL-1α can improve hepatic fibrosis | Zhang et al[94] |
2 | Ginkgo biloba leaf | Rat | MDA, TGF-β1, Col-1 | Effectively regulating the OS thioacetamide-induced hepatic fibrosis | Al-Attar et al[100] | |
3 | Clove basil | Rat | CAT | α-SMA, Col-α | Inhibiting OS can significantly suppress HSC activation, as well as the expressions of α-SMA and Col-α, exhibiting its anti-hepatic fibrosis properties | Chiu et al[103] |
4 | Ceratonia siliqua pod | Mice | GSH, SOD, CAT, GST, GPx, GR | TIMP-2, NO | Inhibiting the production of LPO and NO, increasing the content of GSH, and restoring the activity of antioxidant enzymes can suppress OS, granuloma formation, and hepatic fibrosis | Al-Olayan et al[129] |
5 | Grape seed | Rat | AOC, GSH | TNF-α, MDA, MPO | Inhibiting neutrophil infiltration and lipid peroxidation, suppressing OS, restoring the oxidative and antioxidant status in tissues can help protect against hepatic fibrosis | Dulundu et al[130] |
6 | Pomegranate | Rat | SOD, GST, CAT, Nrf2 | NF-κB, α-SMA, Cox-2 | Reducing OS by regulating Nrf2 and NF-κB can eliminate hepatic fibrosis | Husain et al[131] |
7 | Taraxacum officinale root | Mice | SOD, mt I/II | α-SMA | Inhibiting OS, inducing HSC inactivation and enhancing liver regeneration capacity are effective in the treatment of hepatic fibrosis | Domitrović et al[132] |
8 | Myrtus communis | Rat | GSH, SOD | TNF-α, IL-1β, MDA, MPO, TGF-β | Its antioxidant and free radical scavenging activities protect liver tissue from OS damage after bile duct ligation , thereby exerting its anti-fibrotic effects | Sen et al[133] |
No. | Traditional Chinese medicine formulas | Composition | Efficacy | Model | Upregulated molecules | Downregulated molecules | Mechanism | Ref. |
1 | Yin-Chen-Hao-Tang | Artemisia annua L. 18 g, Gardenia jasminoides Ellis 12 g, Rheum palmatum 6 g | Clearing heat and promoting diuresis to relieve dampness and jaundice | Rat | Col-I, α-SMA, TGF-β, HYP, ROS | Alleviating hepatic fibrosis by enhancing antioxidant capacity, reducing ROS levels, suppressing OS, and inhibiting inflammatory response | Lee et al[106], Mountford et al[108], Chen et al[109] | |
2 | Xiaochaihu Tang (XCHT) | Bupleurum root 12 g, Scutellaria baicalensis 9 g, Ginseng 6g, Pinellia ternata 9 g, Roasted Licorice 5 g, Fresh Ginger 9 g, 4 Red Dates | Soothing liver and relieving depression, regulating stomach and lowering qi counterflow, tonifying qi and strengthening spleen, clearing liver and purging fire | Rat | Nrf2, Nqo1, HO-2, GCLC, GCLM | α-SMA, HA, PCIII, LN | Activating the Nrf2 pathway can attenuate OS and further suppress activated HSCs, thereby improving hepatic fibrosis | Li et al[111], Hu et al[112] |
3 | Fu Zheng Hua Yu Fang | Salvia miltiorrhiza, Fermented Cordyceps sinensis powder, Peach kernel, Pine pollen, Lycopodium clavatum, Schisandra chinensis (processed) | Activating blood circulation and removing blood stasis, nourishing essence and nurturing liver | Mice | α-SMA, Nqo1, HO-2, GCLC, GCLM, TIMP1, TGF-β1, TGF-RI, PDGF-Rβ, MDA, Col-1aI, TGF-βRI, PDGF-β, MCP-1, MIP-1 mRNA | Effectively suppressing the production of liver ROS, inhibiting OS, and exerting anti-fibrotic effects | Jiang et al[116] | |
4 | CGX | Artemisia annua 5g, Trionyx sinensis shell 5g, Radish seed 5g; White Atractylodes 3g, Pogostemon cablin 3g, Alisma orientale 3g, White Atractylodes 3g, Salvia miltiorrhiza 3g; Poria cocos 2g, Aurantium fruit 2g, Amomum cardamomum 2g, Licorice 1g, Saussurea costus 1g | Clearing liver and activating blood circulation, strengthening spleen and transforming dampness | Rat | GSH-Px, GSH-Rd, GST, SOD, IFN-γ | MDA, PDGF-BB, TGF-β1, CTGF | It inhibits the levels of liver tissue HYP and MDA, while increasing the total GSH content and the activity of GSH-oxidation reduction system enzymes, which suppresses OS and exerts its anti-hepatic fibrosis effects | Kim et al[134] |
5 | Huangjia Ruangan Granule | Astragalus membranaceus,Trionyx sinensis shell, Pueraria lobata root, Bupleurum root, Ganoderma lucidum,Paeonia lactiflora, Salvia miltiorrhiza, Panax notoginseng, Lycopodium clavatum, Phyllanthus urinaria | Regulating qi and soothing liver, activating blood circulation and relieving hardness | Rat | SOD, GSH | PC-III, Col-IV, LN, HA, α-SMA, MDA, MPO, TNF-α, IL-1β, IL-6, Cox-2, iNOS, TNFR1, p-IκBα, p-P65/P65, p-ERK/ERK, p-JNK/JNK, MAPK p-P38/P38 | Antagonizing OS effectively inhibits hepatic fibrosis by regulating TNF/MAPK and NF-κB signaling pathways to suppress liver inflammation | Cai et al[135] |
- Citation: Li Z, Zhu JF, Ouyang H. Progress on traditional Chinese medicine in improving hepatic fibrosis through inhibiting oxidative stress. World J Hepatol 2023; 15(10): 1091-1108
- URL: https://www.wjgnet.com/1948-5182/full/v15/i10/1091.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i10.1091